Published in PLoS One on January 05, 2010
The stressed synapse: the impact of stress and glucocorticoids on glutamate transmission. Nat Rev Neurosci (2011) 2.82
Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders. Neuropharmacology (2011) 2.79
Agomelatine, the first melatonergic antidepressant: discovery, characterization and development. Nat Rev Drug Discov (2010) 1.47
NMDA receptor binding in focal epilepsies. J Neurol Neurosurg Psychiatry (2015) 1.42
Overview of glutamatergic neurotransmission in the nervous system. Pharmacol Biochem Behav (2011) 1.18
Magnetic resonance spectroscopy study of the glutamatergic system in adolescent males with high-functioning autistic disorder: a pilot study at 4T. Eur Arch Psychiatry Clin Neurosci (2012) 1.03
Glucocorticoid actions on synapses, circuits, and behavior: implications for the energetics of stress. Front Neuroendocrinol (2013) 1.03
A review on animal models for screening potential anti-stress agents. Neurol Sci (2011) 0.97
Stress and glucocorticoid receptor-dependent mechanisms in long-term memory: from adaptive responses to psychopathologies. Neurobiol Learn Mem (2013) 0.96
The dynamics of the stress neuromatrix. Mol Psychiatry (2016) 0.93
Novel aspects of glucocorticoid actions. J Neuroendocrinol (2014) 0.89
A neurobiological hypothesis of treatment-resistant depression - mechanisms for selective serotonin reuptake inhibitor non-efficacy. Front Behav Neurosci (2014) 0.89
Relationship among Glutamine, γ-Aminobutyric Acid, and Social Cognition in Autism Spectrum Disorders. J Child Adolesc Psychopharmacol (2015) 0.88
A pilot study of hippocampal volume and N-acetylaspartate (NAA) as response biomarkers in riluzole-treated patients with GAD. Eur Neuropsychopharmacol (2012) 0.87
Dentate gyrus-CA3 glutamate release/NMDA transmission mediates behavioral despair and antidepressant-like responses to leptin. Mol Psychiatry (2014) 0.85
The medial prefrontal cortex: coordinator of autonomic, neuroendocrine and behavioural responses to stress. J Neuroendocrinol (2015) 0.83
Blockade of stress-induced increase of glutamate release in the rat prefrontal/frontal cortex by agomelatine involves synergy between melatonergic and 5-HT2C receptor-dependent pathways. BMC Neurosci (2010) 0.83
Ketamine regulates the presynaptic release machinery in the hippocampus. J Psychiatr Res (2013) 0.82
The neurobiological pathogenesis of poststroke depression. ScientificWorldJournal (2014) 0.82
Relevance of chronic stress and the two faces of microglia in Parkinson's disease. Front Cell Neurosci (2015) 0.81
Chronic Stress Increases Prefrontal Inhibition: A Mechanism for Stress-Induced Prefrontal Dysfunction. Biol Psychiatry (2016) 0.81
Agomelatine: mechanism of action and pharmacological profile in relation to antidepressant properties. Br J Pharmacol (2014) 0.80
The neuroenergetics of stress hormones in the hippocampus and implications for memory. Front Neurosci (2015) 0.80
Functional and structural remodeling of glutamate synapses in prefrontal and frontal cortex induced by behavioral stress. Front Psychiatry (2015) 0.78
Chronic desipramine prevents acute stress-induced reorganization of medial prefrontal cortex architecture by blocking glutamate vesicle accumulation and excitatory synapse increase. Int J Neuropsychopharmacol (2014) 0.78
NMDA receptor antagonists ketamine and Ro25-6981 inhibit evoked release of glutamate in vivo in the subiculum. Transl Psychiatry (2014) 0.78
Chronic treatment with agomelatine or venlafaxine reduces depolarization-evoked glutamate release from hippocampal synaptosomes. BMC Neurosci (2013) 0.78
Participation of brainstem monoaminergic nuclei in behavioral depression. Pharmacol Biochem Behav (2011) 0.77
Role of corticosterone in the murine enteric nervous system during fasting. Am J Physiol Gastrointest Liver Physiol (2014) 0.76
Stress Response and Perinatal Reprogramming: Unraveling (Mal)adaptive Strategies. Neural Plast (2016) 0.76
Augmentation therapy with alpha-lipoic acid and desvenlafaxine: a future target for treatment of depression? Naunyn Schmiedebergs Arch Pharmacol (2013) 0.76
Alteration of somatosensory response in adulthood by early life stress. Front Mol Neurosci (2015) 0.76
Protective effects of carnosol against oxidative stress induced brain damage by chronic stress in rats. BMC Complement Altern Med (2017) 0.75
Psychological Stress and Changes of Hypothalamic-Pituitary-Adrenal Axis in Patients with "De Novo" Parkinson's Disease. Med Arch (2016) 0.75
Acute stress enhances the glutamatergic transmission onto basoamygdala neurons embedded in distinct microcircuits. Mol Brain (2017) 0.75
Synaptic Plasticity, Metaplasticity and Depression. Curr Neuropharmacol (2017) 0.75
ErbB3 mRNA leukocyte levels as a biomarker for major depressive disorder. BMC Psychiatry (2012) 0.75
Linear headache: clinical characteristics of eight new cases. Springerplus (2016) 0.75
Long-Term Citalopram Treatment Alters the Stress Responses of the Cortical Dopamine and Noradrenaline Systems: the Role of Cortical 5-HT1A Receptors. Int J Neuropsychopharmacol (2016) 0.75
Delineation of molecular pathway activities of the chronic antidepressant treatment response suggests important roles for glutamatergic and ubiquitin-proteasome systems. Transl Psychiatry (2017) 0.75
Acute Footshock Stress Induces Time-Dependent Modifications of AMPA/NMDA Protein Expression and AMPA Phosphorylation. Neural Plast (2016) 0.75
The Effect of Glucocorticoid and Glucocorticoid Receptor Interactions on Brain, Spinal Cord, and Glial Cell Plasticity. Neural Plast (2017) 0.75
Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science (2003) 28.61
SNAREs--engines for membrane fusion. Nat Rev Mol Cell Biol (2006) 12.74
The synaptic vesicle cycle. Annu Rev Neurosci (2004) 12.25
Physiology and neurobiology of stress and adaptation: central role of the brain. Physiol Rev (2007) 11.15
Stress and the brain: from adaptation to disease. Nat Rev Neurosci (2005) 9.48
The molecular neurobiology of depression. Nature (2008) 6.51
Stress signalling pathways that impair prefrontal cortex structure and function. Nat Rev Neurosci (2009) 6.22
Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders. Nat Rev Drug Discov (2008) 4.46
Stress, depression, and neuroplasticity: a convergence of mechanisms. Neuropsychopharmacology (2007) 4.38
Synaptic vesicle fusion. Nat Struct Mol Biol (2008) 4.22
The stressed hippocampus, synaptic plasticity and lost memories. Nat Rev Neurosci (2002) 4.14
SNARE complex formation is triggered by Ca2+ and drives membrane fusion. Cell (1999) 3.04
Mineralocorticoid receptors are indispensable for nongenomic modulation of hippocampal glutamate transmission by corticosterone. Proc Natl Acad Sci U S A (2005) 2.73
The possibility of neurotoxicity in the hippocampus in major depression: a primer on neuron death. Biol Psychiatry (2000) 2.53
How can drug discovery for psychiatric disorders be improved? Nat Rev Drug Discov (2007) 2.29
A rapid method for isolation of synaptosomes on Percoll gradients. Brain Res (1986) 2.22
Acute stress enhances glutamatergic transmission in prefrontal cortex and facilitates working memory. Proc Natl Acad Sci U S A (2009) 1.95
A simple apparatus for studying the release of neurotransmitters from synaptosomes. Eur J Pharmacol (1974) 1.91
Brain microdialysis of GABA and glutamate: what does it signify? Synapse (1997) 1.78
Glucocorticoids mediate the stress-induced extracellular accumulation of glutamate. Brain Res (1994) 1.59
Minireview: rapid glucocorticoid signaling via membrane-associated receptors. Endocrinology (2006) 1.58
Corticosteroid hormones in the central stress response: quick-and-slow. Front Neuroendocrinol (2007) 1.41
The novel melatonin agonist agomelatine (S20098) is an antagonist at 5-hydroxytryptamine2C receptors, blockade of which enhances the activity of frontocortical dopaminergic and adrenergic pathways. J Pharmacol Exp Ther (2003) 1.40
Rapid glucocorticoid effects on excitatory amino acid levels in the hippocampus: a microdialysis study in freely moving rats. Eur J Neurosci (1999) 1.39
Chronic restraint stress up-regulates GLT-1 mRNA and protein expression in the rat hippocampus: reversal by tianeptine. Proc Natl Acad Sci U S A (2004) 1.30
Chronic antidepressants reduce depolarization-evoked glutamate release and protein interactions favoring formation of SNARE complex in hippocampus. J Neurosci (2005) 1.25
Acute stress-mediated increases in extracellular glutamate levels in the rat amygdala: differential effects of antidepressant treatment. Eur J Neurosci (2007) 1.24
Cellular plasticity for group I mGluR-mediated epileptogenesis. J Neurosci (2009) 1.20
Effect of acute stress on hippocampal glutamate levels and spectrin proteolysis in young and aged rats. J Neurochem (1995) 1.19
Abnormalities of SNARE mechanism proteins in anterior frontal cortex in severe mental illness. Cereb Cortex (2002) 1.18
Assembly of SNARE core complexes prior to neurotransmitter release sets the readily releasable pool of synaptic vesicles. J Biol Chem (2000) 1.18
Learned helplessness in the rat: improvements in validity and reliability. Brain Res Brain Res Protoc (2001) 1.17
Rapid changes in hippocampal CA1 pyramidal cell function via pre- as well as postsynaptic membrane mineralocorticoid receptors. Eur J Neurosci (2008) 1.16
Temporal dynamics of glutamate efflux in the prefrontal cortex and in the hippocampus following repeated stress: effects of pretreatment with saline or diazepam. Neuroscience (1997) 1.15
Synaptosomes still viable after 25 years of superfusion. Neurochem Res (2000) 1.13
New selective ligands of human cloned melatonin MT1 and MT2 receptors. Naunyn Schmiedebergs Arch Pharmacol (2003) 1.11
Regulation of activin mRNA and Smad2 phosphorylation by antidepressant treatment in the rat brain: effects in behavioral models. J Neurosci (2005) 1.03
Physiological elevations of glucocorticoids potentiate glutamate accumulation in the hippocampus. J Neurochem (1994) 1.00
Accumulation of 7S SNARE complexes in hippocampal synaptosomes from chronically kindled rats. J Neurochem (2003) 0.97
Antidepressant treatments and function of glutamate ionotropic receptors mediating amine release in hippocampus. Neuropharmacology (2007) 0.96
Effects of chronic mild stress (CMS) and imipramine administration, on spleen mononuclear cell proliferative response, serum corticosterone level and brain norepinephrine content in male mice. Psychoneuroendocrinology (1999) 0.96
Psychiatric drugs. Excited by glutamate. Science (2003) 0.94
Inducible cAMP early repressor regulates corticosterone suppression after tricyclic antidepressant treatment. J Neurosci (2004) 0.93
Imipramine and phenelzine decrease glutamate overflow in the prefrontal cortex--a possible mechanism of neuroprotection in major depression? Neuroscience (2000) 0.93
Repeated administration of imipramine attenuates glutamatergic transmission in rat frontal cortex. Neuroscience (2008) 0.92
Emerging drugs for schizophrenia. Expert Opin Emerg Drugs (2008) 0.91
Chronic antidepressants induce redistribution and differential activation of alphaCaM kinase II between presynaptic compartments. Neuropsychopharmacology (2007) 0.90
Enhancing AMPA to NMDA throughput as a convergent mechanism for antidepressant action. Drug Discov Today Ther Strateg (2006) 0.87
Homeostatic regulation of glutamate release in response to depolarization. Mol Neurobiol (2006) 0.85
Entrapping of impermeant probes of different size into nonpermeabilized synaptosomes as a method to study presynaptic mechanisms. J Neurochem (2000) 0.85
Differential effects of chronic antidepressant treatment on swim stress- and fluoxetine-induced secretion of corticosterone and progesterone. J Pharmacol Exp Ther (1998) 0.85
Early induction of CREB activation and CREB-regulating signalling by antidepressants. Int J Neuropsychopharmacol (2009) 0.84
Alprazolam treatment immediately after stress exposure interferes with the normal HPA-stress response and increases vulnerability to subsequent stress in an animal model of PTSD. Eur Neuropsychopharmacol (2009) 0.82
Chronic drug treatments induce changes in the sensitivity of presynaptic autoreceptors but not of presynaptic heteroreceptors. Eur J Pharmacol (1983) 0.81
Sound-driven synaptic inhibition in primary visual cortex. Neuron (2012) 2.84
Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders. Neuropharmacology (2011) 2.79
How can drug discovery for psychiatric disorders be improved? Nat Rev Drug Discov (2007) 2.29
Dynamic regulation of glutamatergic postsynaptic activity in rat prefrontal cortex by repeated administration of antipsychotic drugs. Mol Pharmacol (2008) 1.61
Synaptophysin: leading actor or walk-on role in synaptic vesicle exocytosis? Bioessays (2004) 1.55
Signaling pathways regulating gene expression, neuroplasticity, and neurotrophic mechanisms in the action of antidepressants: a critical overview. Pharmacol Rev (2006) 1.51
Neuronal plasticity: a link between stress and mood disorders. Psychoneuroendocrinology (2009) 1.47
TBC1D24, an ARF6-interacting protein, is mutated in familial infantile myoclonic epilepsy. Am J Hum Genet (2010) 1.44
Layer-specific excitatory circuits differentially control recurrent network dynamics in the neocortex. Nat Neurosci (2013) 1.39
Noradrenaline in mood and anxiety disorders: basic and clinical studies. Int Clin Psychopharmacol (2003) 1.34
Postnatal repeated maternal deprivation produces age-dependent changes of brain-derived neurotrophic factor expression in selected rat brain regions. Biol Psychiatry (2004) 1.32
Stress during development: Impact on neuroplasticity and relevance to psychopathology. Prog Neurobiol (2007) 1.31
Phosphatidylinositol 4-kinase type IIalpha is responsible for the phosphatidylinositol 4-kinase activity associated with synaptic vesicles. Proc Natl Acad Sci U S A (2003) 1.28
Neuronal nitric-oxide synthase localization mediated by a ternary complex with synapsin and CAPON. Proc Natl Acad Sci U S A (2002) 1.27
Chronic antidepressants reduce depolarization-evoked glutamate release and protein interactions favoring formation of SNARE complex in hippocampus. J Neurosci (2005) 1.25
Lack of synapsin I reduces the readily releasable pool of synaptic vesicles at central inhibitory synapses. J Neurosci (2007) 1.25
Direct evidence that release-stimulating alpha7* nicotinic cholinergic receptors are localized on human and rat brain glutamatergic axon terminals. J Neurochem (2002) 1.25
Phosphorylation of spinophilin modulates its interaction with actin filaments. J Biol Chem (2002) 1.23
Synapsin I is an oligomannose-carrying glycoprotein, acts as an oligomannose-binding lectin, and promotes neurite outgrowth and neuronal survival when released via glia-derived exosomes. J Neurosci (2011) 1.23
SYN1 loss-of-function mutations in autism and partial epilepsy cause impaired synaptic function. Hum Mol Genet (2011) 1.23
Remote control of induced dopaminergic neurons in parkinsonian rats. J Clin Invest (2014) 1.23
Protein sorting in the synaptic vesicle life cycle. Prog Neurobiol (2006) 1.23
Selective phosphorylation of nuclear CREB by fluoxetine is linked to activation of CaM kinase IV and MAP kinase cascades. Neuropsychopharmacology (2004) 1.23
Desmethylclomipramine induces the accumulation of autophagy markers by blocking autophagic flux. J Cell Sci (2009) 1.20
Structural domains involved in the regulation of transmitter release by synapsins. J Neurosci (2005) 1.19
Impact of selective decontamination of the digestive tract on fungal carriage and infection: systematic review of randomized controlled trials. Intensive Care Med (2005) 1.18
Opposite changes in glutamatergic and GABAergic transmission underlie the diffuse hyperexcitability of synapsin I-deficient cortical networks. Cereb Cortex (2008) 1.17
Repeated exposure to cocaine differently modulates BDNF mRNA and protein levels in rat striatum and prefrontal cortex. Eur J Neurosci (2007) 1.17
Ryanodine receptor blockade reduces amyloid-β load and memory impairments in Tg2576 mouse model of Alzheimer disease. J Neurosci (2012) 1.16
Protein kinase A-mediated synapsin I phosphorylation is a central modulator of Ca2+-dependent synaptic activity. J Neurosci (2006) 1.15
Cyclo-oxygenase-1 and -2 differently contribute to prostaglandin E2 synthesis and lipid peroxidation after in vivo activation of N-methyl-D-aspartate receptors in rat hippocampus. J Neurochem (2005) 1.15
Synapsin-I- and synapsin-II-null mice display an increased age-dependent cognitive impairment. J Cell Sci (2008) 1.14
Novel compound heterozygous mutations in TBC1D24 cause familial malignant migrating partial seizures of infancy. Hum Mutat (2013) 1.13
Communication breaks-Down: from neurodevelopment defects to cognitive disabilities in Down syndrome. Prog Neurobiol (2010) 1.13
Synaptophysin I controls the targeting of VAMP2/synaptobrevin II to synaptic vesicles. Mol Biol Cell (2003) 1.13
Simultaneous two-photon imaging and photo-stimulation with structured light illumination. Opt Express (2010) 1.12
Enriched experience and recovery from amblyopia in adult rats: impact of motor, social and sensory components. Neuropharmacology (2012) 1.11
Using the atomic force microscope to study the interaction between two solid supported lipid bilayers and the influence of synapsin I. Biophys J (2004) 1.11
Dynamic interaction of amphiphysin with N-WASP regulates actin assembly. J Biol Chem (2009) 1.10
Chronic duloxetine treatment induces specific changes in the expression of BDNF transcripts and in the subcellular localization of the neurotrophin protein. Neuropsychopharmacology (2007) 1.10
Chronic antidepressant treatments increase basic fibroblast growth factor and fibroblast growth factor-binding protein in neurons. Neuropharmacology (2008) 1.10
Glia re-sealed particles freshly prepared from adult rat brain are competent for exocytotic release of glutamate. J Neurochem (2006) 1.09
Blood microRNA changes in depressed patients during antidepressant treatment. Eur Neuropsychopharmacol (2012) 1.08
The role of synapsins in neuronal development. Cell Mol Life Sci (2009) 1.07
Lithium rescues synaptic plasticity and memory in Down syndrome mice. J Clin Invest (2012) 1.07
Classification framework for graphene-based materials. Angew Chem Int Ed Engl (2014) 1.06
Identification of a developmentally regulated pathway of membrane retrieval in neuronal growth cones. J Cell Sci (2008) 1.06
Regulation of editing and expression of glutamate alpha-amino-propionic-acid (AMPA)/kainate receptors by antidepressant drugs. Biol Psychiatry (2006) 1.05
Glucocorticoid receptor and FKBP5 expression is altered following exposure to chronic stress: modulation by antidepressant treatment. Neuropsychopharmacology (2012) 1.04
Dominant β-catenin mutations cause intellectual disability with recognizable syndromic features. J Clin Invest (2014) 1.04
Phosphorylation of synapsin I by cAMP-dependent protein kinase controls synaptic vesicle dynamics in developing neurons. J Neurosci (2005) 1.04
The action of antidepressants on the glutamate system: regulation of glutamate release and glutamate receptors. Biol Psychiatry (2012) 1.04
Association between promoter polymorphic haplotypes of interleukin-10 gene and schizophrenia. Biol Psychiatry (2002) 1.03
Stimulation of excitatory amino acid release from adult mouse brain glia subcellular particles by high mobility group box 1 protein. J Neurochem (2006) 1.02
Mode of action of agomelatine: synergy between melatonergic and 5-HT2C receptors. World J Biol Psychiatry (2011) 1.02
Acute stress responsiveness of the neurotrophin BDNF in the rat hippocampus is modulated by chronic treatment with the antidepressant duloxetine. Neuropsychopharmacology (2008) 1.02
ERK activation in axonal varicosities modulates presynaptic plasticity in the CA3 region of the hippocampus through synapsin I. Proc Natl Acad Sci U S A (2009) 1.02
Synapsin II desynchronizes neurotransmitter release at inhibitory synapses by interacting with presynaptic calcium channels. Nat Commun (2013) 1.01
TBC1D24 regulates neuronal migration and maturation through modulation of the ARF6-dependent pathway. Proc Natl Acad Sci U S A (2014) 1.01
Fluoxetine and olanzapine have synergistic effects in the modulation of fibroblast growth factor 2 expression within the rat brain. Biol Psychiatry (2004) 1.00
Enteral vancomycin to control methicillin-resistant Staphylococcus aureus outbreak in mechanically ventilated patients. Am J Infect Control (2002) 1.00
Biochemical and electrophysiological changes of substantia nigra pars reticulata driven by subthalamic stimulation in patients with Parkinson's disease. Eur J Neurosci (2006) 0.99
Environmental enrichment decreases GABAergic inhibition and improves cognitive abilities, synaptic plasticity, and visual functions in a mouse model of Down syndrome. Front Cell Neurosci (2011) 0.99
Strategies to maximize the performance of a STED microscope. Opt Express (2012) 0.99
Cellular and molecular mechanisms in the long-term action of antidepressants. Dialogues Clin Neurosci (2008) 0.99
Nanostructured superhydrophobic substrates trigger the development of 3D neuronal networks. Small (2012) 0.98
Autism-related behavioral abnormalities in synapsin knockout mice. Behav Brain Res (2012) 0.98
Regulated delivery of AMPA receptor subunits to the presynaptic membrane. EMBO J (2003) 0.98
Reduced neuroplasticity in aged rats: a role for the neurotrophin brain-derived neurotrophic factor. Neurobiol Aging (2013) 0.97
Emergent functional properties of neuronal networks with controlled topology. PLoS One (2012) 0.97
Traffic of botulinum toxins A and E in excitatory and inhibitory neurons. Traffic (2007) 0.97
Prenatal stress elicits regionally selective changes in basal FGF-2 gene expression in adulthood and alters the adult response to acute or chronic stress. Neurobiol Dis (2005) 0.96
Antidepressant treatments and function of glutamate ionotropic receptors mediating amine release in hippocampus. Neuropharmacology (2007) 0.96
A hybrid bioorganic interface for neuronal photoactivation. Nat Commun (2011) 0.96
The pharmacological properties of antidepressants. Int Clin Psychopharmacol (2010) 0.96
SK channel modulation rescues striatal plasticity and control over habit in cannabinoid tolerance. Nat Neurosci (2012) 0.96